相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
Haidee Aranda-Tavio et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
Valentina R. Minciacchi et al.
CELLS (2021)
PKC-β/Alox5 axis activation promotes Bcr-Abl-independent TKI-resistance in chronic myeloid leukemia
Dan Ma et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Response and Resistance to BCR-ABL1-Targeted Therapies
Theodore P. Braun et al.
CANCER CELL (2020)
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Michael Teufel et al.
GASTROENTEROLOGY (2019)
STAT5 and STAT5 Inhibitors in Hematological Malignancies
Manlio Tolomeo et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
Luana Bavaro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MicroRNA-221 sensitizes chronic myeloid leukemia cells to imatinib by targeting STAT5
Xiaoxiao Jiang et al.
LEUKEMIA & LYMPHOMA (2019)
Direct Targeting Options for STAT3 and STAT5 in Cancer
Anna Orlova et al.
CANCERS (2019)
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Rebecca Mitchell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Rebecca Mitchell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation
Bowen Dong et al.
SCIENCE CHINA-LIFE SCIENCES (2018)
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
Karoline V. Gleixner et al.
HAEMATOLOGICA (2017)
New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias
Ludovic Juen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Andreas Hochhaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
Karoline V. Gleixner et al.
HAEMATOLOGICA (2017)
Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis
Elif Birtas Atesoglu et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2016)
Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis
Elif Birtas Atesoglu et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2016)
Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer
Sophia Pinz et al.
BMC MOLECULAR BIOLOGY (2016)
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
Hannah Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Targeting Tie2 and the host vascular response in sepsis
Samir M. Parikh
SCIENCE TRANSLATIONAL MEDICINE (2016)
Src family kinases and their role in hematological malignancies
Matthew Ku et al.
LEUKEMIA & LYMPHOMA (2015)
Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack
Italia Grenga et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy
Siham Bibi et al.
HAEMATOLOGICA (2014)
Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors
Christine Victoria Ichim
STEM CELLS TRANSLATIONAL MEDICINE (2014)
Adding a new facet to STAT5 in CML Multitasking for leukemic cells
Wolfgang Warsch et al.
CELL CYCLE (2013)
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias
J. E. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment
Su Chu et al.
BLOOD (2011)
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Jorge E. Cortes et al.
BLOOD (2011)
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
C-L Cheng et al.
BRITISH JOURNAL OF CANCER (2011)
Angiopoietin-1 and -2 Exert Antagonistic Functions in Tumor Angiogenesis, yet Both Induce Lymphangiogenesis
Ernesta Fagiani et al.
CANCER RESEARCH (2011)
Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors
Juan Carlos Montero et al.
CLINICAL CANCER RESEARCH (2011)
Targeting the ANGPT-TIE2 pathway in malignancy
Hanhua Huang et al.
NATURE REVIEWS CANCER (2010)
Discovery of chromone-based inhibitors of the transcription factor STAT5
Judith Mueller et al.
CHEMBIOCHEM (2008)
Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer
Xiao-Hong Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia
C-Y Lee et al.
BRITISH JOURNAL OF CANCER (2007)
STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases
Alireza Mirmohammadsadegh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Combined AN inhibitor therapy for minimizing drug resistance in chronic myeloid leukemia: Src/Abl inhibitors are compatible with imatinib
T O'Hare et al.
CLINICAL CANCER RESEARCH (2005)
Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche
F Arai et al.
CELL (2004)
Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
T Torimura et al.
JOURNAL OF HEPATOLOGY (2004)
Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway
Y Okutani et al.
ONCOGENE (2001)
分享论文
